July 09, 2016
1 min read
Save

ASH presents research training awards to seven fellows

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ASH announced seven recipients of the 2016 ASH Research Training Award for Fellows, a yearlong program designed to encourage careers in academic hematology by providing protected research during training.

Charles S. Abrams, MD

Charles S. Abrams

“Fellows who conduct high-quality research during their training improve their chances of receiving an academic appointment and research funding to start their careers; however, it is often difficult to devote time to research,” ASH president Charles S. Abrams, MD, said in a press release. “By supporting protected time for scientific exploration, the [training] award positions the next generation of physician–scientists for successful careers in hematology.” 

This year’s recipients and their research topics are:

•          Waitmann Aumann, MD, of Duke University Hospital — CRM1 dimerization in CALM-AF10 leukemia;

•          Shruti Chaturvedi, MBBS, of Vanderbilt University — Alternate pathway of complement in adults with sickle cell disease and acute chest syndrome;

•          Gordon Cohen, MD, MPH, of The Johns Hopkins University — Overcoming imatinib (Gleevec, Novartis) resistance in pediatric Philadelphia chromosome–positive acute lymphocytic leukemia;

•          Anna Halpern, MD, of University of Washington — Developing and testing models to predict ICU admission and mortality for adults with acute myeloid leukemia;

•          Sakiko Suzuki, MD, of University of Massachusetts — Novel therapy of leukemia through alternative splicing of MPL;

•          Justin Taylor, MD, of Memorial Sloan Kettering Cancer Center — Biological and mechanistic effects of XPO1 alterations in hematopoietic malignancies; and

•          Amy Tang, MD, of NewYork-Presbyterian Hospital — Transfusion-related iron overload and posttransplantation outcomes in a chemotherapy-based mouse model of allogeneic stem cell transplant.